New vaginal tablet shows promise for yeast infections in small study
NCT ID NCT05507333
First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 32 times
Summary
This study tested a new vaginal tablet (Gedea Pessary) in 26 adult women with yeast infections. Women used one tablet daily for 6 days. The main goal was to see if symptoms like itching and burning went away by day 7 or 14. The study also checked if the infection came back by day 25 and monitored safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVOVAGINAL CANDIDIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTC MTC
Uppsala, 75237, Sweden
-
Carlanderska
Gothenburg, 405 45, Sweden
-
Danderyds sjukhus
Stockholm, 182 88, Sweden
-
KS Huddinge
Stockholm, 141 86, Sweden
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.